
USPH Stock Forecast & Price Target
USPH Analyst Ratings
Bulls say
US Physical Therapy Inc. has demonstrated a positive financial trajectory, highlighted by a sequential commercial pricing increase of 2.2%, indicating a solid demand for its services. The industrial injury prevention (IIP) segment reported remarkable revenue growth of 22.2% overall, with a substantial 18.4% increase when excluding contributions from mergers and acquisitions. This performance underscores the company's strong operational fundamentals and its ability to capitalize on multiple revenue streams from both physical therapy operations and industrial injury prevention services.
Bears say
US Physical Therapy has experienced a decline in a key financial metric, with an observed decrease of 0.6% to $83.95 from $84.46 in the comparable period a year ago, highlighting potential stagnation in revenue growth. The company has faced continuous reimbursement cuts over the past five years, culminating in a substantial $20 million headwind to profitability, which raises concerns about its financial sustainability. Additionally, the company's operational expenses have slightly exceeded estimates, with rent and clinic costs comprising 20.2% of revenue, further straining its profitability outlook.
This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.
USPH Analyst Forecast & Price Prediction
Start investing in USPH
Order type
Buy in
Order amount
Est. shares
0 shares